In a move poised to reshape the global metabolic API landscape, renowned Viking pharmaceutical company Rune Pharmaceuticals has announced a groundbreaking strategic alliance with a well-established American Tirzepatide firm. This partnership will see both entities collaborate on optimizing the supply chain for metabolic APIs, ensuring uninterrupted